BOSTON (AP) — BOSTON (AP) — Monte Rosa Therapeutics Inc. (GLUE) on Thursday reported a loss of $44.5 million in its first quarter.
The Boston-based company said it had a loss of 45 cents per share.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.
The biopharmaceutical company posted revenue of $4.2 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $21.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLUE at https://www.zacks.com/ap/GLUE
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
